Klinik İzole Sendrom ve Multipl Sklerozda Fosforile Nörofilament Ağır Zinciri (pNFH)

Conflict of Interest: The authors have no potential conflicts of interest to disclose. Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius Å, Liman V, Norgren N, Blennow K, Zetterberg H. Comparison of three analytical platforms for quantification of the neurofilament light chain in bloo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Noro-Psikiyatri Arsivi 2021-12, Vol.58 (4), p.255-256
Hauptverfasser: Tüzün, Erdem, Şanli, Elif, Akbayir, Ece, Türkoğlu, Recai
Format: Artikel
Sprache:tur
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Conflict of Interest: The authors have no potential conflicts of interest to disclose. Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius Å, Liman V, Norgren N, Blennow K, Zetterberg H. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S, Kappos L, Zipp F, Bittner S. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
ISSN:1300-0667
1309-4866
DOI:10.29399/npa.28019